inclusion body myopathy with Paget disease and frontotemporal dementia

Target entity: inclusion body myopathy with Paget disease and frontotemporal dementia
Context triple: [TDP-43 proteinopathy, associatedWithDisease, inclusion body myopathy with Paget disease and frontotemporal dementia]

• A. TDP-43 proteinopathy
  TDP-43 proteinopathy is a neurodegenerative condition characterized by abnormal aggregation and mislocalization of the TDP-43 protein, commonly implicated in disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
• B. SOD1
  SOD1 is a gene encoding the antioxidant enzyme superoxide dismutase 1, whose mutations are a major known cause of familial amyotrophic lateral sclerosis (ALS).
• C. Cln3
  Cln3 is a G1 cyclin in budding yeast that helps trigger the Start transition of the cell cycle by activating the Cdc28 cyclin-dependent kinase.
• D. C9orf72
  C9orf72 is a human gene whose hexanucleotide repeat expansions are the most common known genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
• E. progressive supranuclear palsy
  Progressive supranuclear palsy is a rare neurodegenerative movement disorder characterized by early postural instability, vertical gaze palsy, and cognitive and behavioral changes due to widespread tau pathology in the brain.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target entity: inclusion body myopathy with Paget disease and frontotemporal dementia
Target entity description: Inclusion body myopathy with Paget disease and frontotemporal dementia is a rare, inherited multisystem degenerative disorder characterized by progressive muscle weakness, bone abnormalities, and early-onset cognitive and behavioral decline.

• A. TDP-43 proteinopathy
  TDP-43 proteinopathy is a neurodegenerative condition characterized by abnormal aggregation and mislocalization of the TDP-43 protein, commonly implicated in disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
• B. SOD1
  SOD1 is a gene encoding the antioxidant enzyme superoxide dismutase 1, whose mutations are a major known cause of familial amyotrophic lateral sclerosis (ALS).
• C. Cln3
  Cln3 is a G1 cyclin in budding yeast that helps trigger the Start transition of the cell cycle by activating the Cdc28 cyclin-dependent kinase.
• D. C9orf72
  C9orf72 is a human gene whose hexanucleotide repeat expansions are the most common known genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
• E. Pompe disease
  Pompe disease is a rare inherited metabolic disorder caused by deficiency of the enzyme acid alpha-glucosidase, leading to progressive muscle weakness and cardiomyopathy due to glycogen buildup in cells.
• F. None of above. chosen